Burning Rock Biotech (BNR) Total Liabilities (2019 - 2025)

Burning Rock Biotech's Total Liabilities history runs 7 years deep, the most recent figure standing at $40.2 million for Q4 2025.

• In Q4 2025, Total Liabilities fell 5.17% year-over-year to $40.2 million; the TTM figure through Dec 2025 stood at $40.2 million (down 5.17% YoY), while the FY2025 annual figure was $40.8 million, down 2.26% from the prior year.
• Total Liabilities was $40.2 million for Q4 2025 at Burning Rock Biotech, up from $36.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $71.5 million in Q1 2022 to a low of $36.4 million in Q2 2025.
• Historically, Total Liabilities has averaged $50.1 million across 5 years, with a median of $49.0 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Total Liabilities surged 85.57% in 2021, then slumped 37.48% in 2023.
• A 5-year view of Total Liabilities shows it stood at $67.8 million in 2021, then retreated by 10.97% to $60.3 million in 2022, then plunged by 37.48% to $37.7 million in 2023, then increased by 12.37% to $42.4 million in 2024, then decreased by 5.17% to $40.2 million in 2025.
• The last three Total Liabilities figures came in at $40.2 million (Q4 2025), $36.9 million (Q3 2025), and $36.4 million (Q2 2025), per Business Quant data.